Experimental studies on multiorgan toxicity of cyclosporine-A in rats using a radiopharmaceutical and comparison with histopathological findings

Abstract

Iodine-125 HIPDM was evaluated as a screening agent for studying multiorgan toxicity due to Cyclosporine-A (CsA) and the results were compared to histopathological findings of the tissues. The rats were injected subcuta neously with 50 mg/kg (body weight) of CsA or with equal volume of the vehicle, Cremophor-EL, for 7 consecutive days. A dose of 10 μCi of I-125 HIPDM was injected intravenously at the end of the treatment period. The results indicated that there was a significant increase in the uptake of 1-125 HIPDM in the kidney, liver, heart and blood compared to control rats (P < 0.05). However, there was a significant decrease in the uptake of 1-125 HIPDM in the spleen compared to control animals (P < 0.001). The lung and brain of CsA treated rats showed no change in the uptake of I-125 HIPDM when compared to control rats.

The change in the uptake of I-125 HIPDM in these organs was assumed to indicate tissue response to the toxic effects of CsA. The radiopharmaceutical results were compar able with the histopathological findings in which the organs showed varying degrees of tissue degeneration. It is concluded that the lipophilic radiopharmaceutical, 1-125 HIPDM, can be used as an effective screening agent to study multiorgan toxicity due to CsA.

Keywords

cyclosporine-A multiorgan toxicity radiopharmaceu tical 1-125 HIPDM histopathology rats

Get full access to this article

View all access options for this article.

References

Valdes Olmes RA , Hoefnagel CA , Van der Schoot JB Nuclear Medicine in the monitoring of organ function and the detection of injury related to Cancer therapy. Eur J Nucl Med 1993; 20: 515-46.

Owunwanne A. , Patel M. , Sadek S. Drugradiopharmacuetical interactions. In The Handbook of Radiopharmaceutials Chapman & Hall Medical: London , 1995, pp43-56.

Hladik III WB , Nigg KK , Rhodes BA Drug-induced changes in the biological distribution of radiopharmaceutical. Semin Nucl Med 1982 ; 184-218.

Carr EA , Carroll M. , Montes M. Effect of vitamin D3. Other drugs altering serum calcium or phosphorus concentrations and deoxycorticosterone on the distribution of Tc-99m pyrophosphate between target and non-target tissues. J Nucl Med 1981; 22: 526-34.

Starzl TE et al. The use of Cyclosporine-A and prednisone in cadaveric kidney transplantation. Surg Gynecol Obstet 1981; 151: 17-26.

Ferguson RM et al. Cyclosporine in renal transplantation: a prospective randomized trial. Surgery 1982; 92: 175-82.

Painvin GA et al. Cardiac transplantation: current results of cyclosporine-treated patients at the Texas Heart Institute. Transplant Proc 1985; 17: 223-4.

Griffith BP , Hardesty RL , Thompson ME Cardiac transplantation with cyclosporine. The Pittsburg experience. J Heart Transplant 1983; 2: 251-6.

Merion RM et al. Cyclosporine: five years experience in cadaveric renal transplantation . New Engl J Med 1984; 310: 148 -54.

10.

Gluckman E. et al. Nephrotoxicity of CyA in a bone marrow transplantation. Lancet 1981; 2: 144-5.

11.

Klintmalm Gbg , Iwatuski S. , Starzl TE Nephrotoxicity of Cyclosporine-A in liver and kidney transplant patient. Lancet 1981 ; 1: 470-1.

12.

Schade RR , Gugliemi A. , Van Thiel DA. Cholestasis in heart transplant recipients treated with cyclosporine. Transplant Proc 1983; 15(Suppl. 1): 2757-60.

13.

Stone BG et al. Cyclosporine A-induced cholestasis; the mechanism in a rat model . Gastroenterology 1987; 93(2): 344-51.

14.

Blair JT et al. Toxicity of the immune suppressant Cyclosporine A in the rat . J Pathology 1982; 138: 163 -78.

15.

Farthing Jjg et al. Nature of the toxicity of Cyclosporine A in the rat. Biochem Pharm 1981; 30: 3311-16.

16.

Boland J. et al. Tissue distribution and toxicity of cyclosporine-A in the mouse . Pathology 1984; 16: 117-23.

17.

Ptachcinski RJ , Venkataramanan R. , Burckart GJ Clinical pharmacokinetics of cyclosporine. Clin Pharmacokin 1986; 11: 107-32.

18.

Loertscher R. et al. Hyperbilirubinemia and cyclosporin-A levels in renal transplant patients. Lancet 1981; 2: 635-6.

19.

Prescott MC , Testa HJ , Lawson RS , Johnson Rwg. The effect of cyclosporine A on the result of radionuclide investigations of kidney function in renal transplant recipients. In Radionuclide in Nephrology. Joekes AM , Constable AR , Brown NJG , Tauxe WN (ed), Academic Press Grune & Stratton: New York, 1988, pp275-9.

20.

Loken MK , Ascher NL , Boudreau RJ , Najarian JS Scintigraphic evaluation of liver transplant function. J Nucl Med 1986; 27: 451-9.

21.

Owunwanne A. et al. The study of the effect of cyclosporine-A on bile flow in experimental animal using technetium-99m EHIDA. Am J of Physiol Imaging 1990; 5: 30-5.

22.

McAfee JG et al. Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents. J Nucl Med 1988; 29: 1577-81.

23.

Kung HF , Trampsosch KM , Blau M. A new brain perfusion imaging agent: [I-125] HIPDM: N,N,N'trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine . J Nucl Med 1983; 24: 66-72.

24.

Atkinson K. et al. Cyclosporine A associated nephrotoxicity in the first 100 days after allogenic bone marrow transplantation. Three distinct syndromes. British Journal of Haematology 1983; 54: 59-67.

25.

Leunissen Kml et al. Impairment of liver synthetic function and decreased liver flow during cyclosporine A therapy. Transplant Proc 19: (I-pt2): 1822-4.

26.

Owunwanne A. et al. Is cyclosporine toxic to the heart? Heart Lung Transplantation 1993; 12(2): 199-204.

27.

Suzuki S. , Kanashiro M. , Amemiya N. Effect of new immuno-suppressant, 15-deoxyspergualin, on heterototopic rat heart transplantation, in comparison with cyclosporine. Transplantation 1987; 44: 483-7.

28.

Chako AK , Gardon DH , Bennett JM Myocardial imaging with Tc-99m pyrophosphate in patients on adriamycin treatment of neoplasia. J Nucl Med 1977; 18: 680-3.

29.

Lekakis J. , Vassilopoulos N. , Psichoyiou H. Doxorubicin cardiotoxicity detected by indium-111 myosin specific imaging . Eur J Nucl Med 1991; 18: 225-6.

30.

Backman L. , Brandt I. , Ringden O. , Dallner G. Distribution of H3 Cyclosporine-A in mice by autoradiography. Transplant Proc 1987; 19: 1236-9.